Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 casesBNT162b2 mRNA COVID-19 백신 후 발생하는 구강 편평태선: 2건의 보고Case Reports Published on 2022-09-012022-09-11 Journal: Oral surgery, oral medicine, oral pathology and or [Category] 변종, [키워드] Adverse reaction Adverse reactions arising BNT162b2 BNT162b2 mRNA COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine effective effort Germany Lichen planus Mainz New York occurred oral lichen planus Pfizer report reported required Vaccine Vaccines variant [DOI] 10.1016/j.oooo.2022.04.003 PMC 바로가기 [Article Type] Case Reports
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China비활성화된 4가 인플루엔자 백신과 함께 투여된 SARS-CoV-2 비활성화된 백신(CoronaVac)의 면역원성 및 안전성: 중국에서 18세에서 59세 사이의 건강한 성인을 대상으로 한 무작위, 공개, 대조 연구Randomized Controlled Trial Published on 2022-08-262022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 95% confidence interval administration Adverse reaction antibody assigned China comparable Concomitant Concomitant administration conducted CoronaVac COVID-19 COVID-19 vaccine dose enrolled Evidence feasible first dose GMT groups healthy immune response immunogenicity inactivated Inactivated vaccine Influenza influenza vaccine Mild moderate MOST non-inferiority Occurrence Open-label participant per-protocol randomization Randomized Randomly receive regimen SARS-CoV-2 Seasonal influenza second dose seroconversion rate two-sided Vaccine Zhejiang [DOI] 10.1016/j.vaccine.2022.07.021 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in ChileArticle Published on 2022-08-242022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, 치료기술, [키워드] activate acute respiratory syndrome Adverse reaction age analyzed binding domain blood sample cellular characterized Chilean circulating clinical trial CoronaVac coronavirus coronavirus 2 coronavirus disease COVID-19 dose effective vaccine enrolled healthy humoral IFN-γ IgG immunogenicity Immunoglobulin inactivated incidence induce injection interferon-γ Local measure Mild neutralizing antibody neutralizing capacity Pain peptide Phase 3 phase 3 clinical trial Placebo pool profiles promote Randomly RBD Registered reported respiratory Safe Safety SARS-CoV-2 SARS-CoV-2 antigens second dose secretion separated severe adverse event significant increase subset T cells T-cell Response the vaccine Vaccine Vaccines Volunteer volunteers was performed [DOI] 10.1093/cid/ciab823 PMC 바로가기
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis2~21세의 건강하고 면역이 억제된 소아 및 청소년을 대상으로 한 코로나19 감염에 대한 백신의 면역학적 반응, 효능 및 안전성: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-08-012022-09-11 Journal: Journal of Clinical Virology [Category] 변종, 임상, [키워드] abort Adenovirus Adolescent adolescents Adverse reaction Adverse reactions assessment BBIBP-CorV BNT162b2 children clinical trials collected conditions CoronaVac COVID-19 COVID-19 pandemic COVID-19 vaccination Efficacy evaluated healthy children immune response immune systems immunization Immunologic Immunosuppressed JNJ-78436735 Mental Meta-analysis Moderna mRNA mRNA-1273 myocarditis Myopericarditis outcomes participant Pfizer physical Prevent proportion PROSPERO Registered reported resolved review Safety safety profile second dose Severe infection Sinopharm Sinovac suppressed systematic review Transmission underlying disease underlying diseases vaccination Vaccine variant vectored vaccine [DOI] 10.1016/j.jcv.2022.105196 PMC 바로가기 [Article Type] Meta-Analysis
Analysis of older adults visiting the emergency department with fever as a suspected Covid-19 vaccine-related adverse reaction: A retrospective multicenter studyObservational Study Published on 2022-08-012022-10-05 Journal: Journal of infection and chemotherapy : official j [Category] 임상, [키워드] Admission Adults Adverse Adverse reaction Adverse reactions age Clinical data clinical feature collected conducted COVID-19 COVID-19 vaccination COVID-19 vaccine Emergency emergency department febrile female Fever Imaging tests initiated investigated Laboratory less medical condition Medical conditions medical records medical service Older older adult Older adults Patient patients postvaccination presenting reported required retrospective Retrospective multicenter study rigor selected the median [DOI] 10.1016/j.jiac.2022.04.022 PMC 바로가기 [Article Type] Observational Study
Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus백만 건 이상의 COVID-19 백신 접종의 실제 증거는 수두 대상포진 바이러스의 재활성화와 일치합니다Article Published on 2022-08-012022-09-11 Journal: Journal of the European Academy of Dermatology and [Category] Coronavirus, MERS, 대상포진, 두창, 수두, 진단, 치료기술, 홍역, [키워드] 95% CI 95% confidence interval accounted Adverse drug reaction adverse event Adverse reaction age and gender assumed calculated cause clinic Cohort COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines database detectable diagnosed drug reaction eruption Evidence Frequency herpes zoster humans Hypothesis incidence individual Infection initial large cohort log-rank test mitigate molecular basis Odds ratio Pathogenesis Patient patients Reactivation real-world data retrieved risk risk ratio shingle shingles significantly higher statistically subject synonym T-cell-mediated immunity vaccination Vaccine Vaccines Varicella-Zoster Virus virus with infections [DOI] 10.1111/jdv.18184 PMC 바로가기 [Article Type] Article
Adverse events following COVID-19 vaccination: A systematic review and meta-analysisResearch article Published on 2022-08-012022-10-05 Journal: International immunopharmacology [Category] 비임상, 임상, [키워드] 95% CI Adverse adverse event adverse events Adverse reaction approved benefit calculated clinical trial control group COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines database DNA DNA vaccine Efficacy Efficacy and safety event greater immunization Inactivated vaccine ISI Local Meta-analysis mRNA mRNA vaccine Occurrence protein subunit vaccine raised Result risk Safety SARS-CoV-2 searched systematic review systemic adverse reaction systemic and local vaccination Vaccine Vaccines WHO [DOI] 10.1016/j.intimp.2022.108906 [Article Type] Research article
Childhood COVID-19 vaccine acceptance and preference from caregivers and healthcare workers in China: A survey experimentRandomized Controlled Trial Published on 2022-08-012022-10-04 Journal: Preventive medicine [Category] 임상, [키워드] acceptance Adverse reaction age approval assigned attribute attributes Child childhood children China conducted Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine Effect Efficacy eight experiment HCW HCWs Health care worker healthcare worker Immunity independent information Odds ratio parental Randomly receive respondent risk survey Survey experiment. vaccination Vaccine [DOI] 10.1016/j.ypmed.2022.107138 PMC 바로가기 [Article Type] Randomized Controlled Trial
Asia Pacific perspectives on the second year of the COVID-19 pandemic: A follow-up surveyCOVID-19 대유행 2년차에 대한 아시아 태평양 전망: 후속 조사Article Published on 2022-08-012022-09-12 Journal: Clinical and experimental allergy : journal of the [Category] Coronavirus, 진단, [키워드] Adverse reaction anaphylaxis Anti-viral anticipated Asia Baricitinib Care changes in cilgavimab clinical complement contributed Coronavirus disease 2019 country COVID-19 COVID-19 disease COVID-19 vaccination programme Dexamethasone Endemic endemic diseases Epidemiology Follow-up force incidence males mild-to-moderate disease morbidity and mortality mRNA neutralizing antibody novel Pacific Association pandemic Perspective preventive measures Prophylaxis public health public health measure question Remdesivir response Ritonavir severe disease Severe infection survey Therapeutics Tixagevimab vaccination Vaccine [DOI] 10.1111/cea.14191 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialRandomized Controlled Trial Published on 2022-08-012022-10-05 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI Adenovirus Administered Adverse reaction agency assigned boost booster dose booster vaccination Booster vaccine China Chinese Controlled trial CoronaVac COVID-19 vaccine development dose evaluate foundation geometric mean titre GMT GMTs Health Heterologous High dose homologous homologous or heterologous immunogenic inactivated incidence individual infection with SARS-CoV-2 intramuscular vaccination Jiangsu Laboratory less live SARS-CoV-2 low dose NAbs natural neutralising antibody Open-label participant primary endpoint priming Program randomised Randomly receive Registered reported Safe Safety SARS-CoV-2 SARS-CoV-2 vaccine Science serum significantly significantly higher Trial vaccination viral particle virus waning immunity [DOI] 10.1016/S2213-2600(22)00087-X PMC 바로가기 [Article Type] Randomized Controlled Trial